✨ Free AI Report
Xtant Medical Holdings, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Xtant Medical Holdings, Inc.
Company Research

Xtant Medical Holdings, Inc.: Business Overview, Financials & Competitive Analysis

Xtant Medical Holdings, Inc. scores 4/10 on the AskCyborg Cyborg Score (Mixed). Turnaround candidate with strong orthobiologics core but facing financial distress and requiring successful execution of strategic refocusing. The company's Altman Z-Score of -0.56 places Xtant in the distress zone, implying a potential risk of financial instability. However, Q1 2025 showed revenue increases of 18% year-over-year with positive net.

What is Xtant Medical Holdings, Inc.'s industry? Xtant Medical Holdings, Inc. (xtantmedical.com) operates in Medical Devices - Orthobiologics and Spinal Implants. AskCyborg classifies Xtant Medical Holdings, Inc. under Medical Devices - Orthobiologics and Spinal Implants in its company registry.

Xtant Medical is a tissue bank and developer of orthobiologics and spinal fixation systems headquartered in Montana. The company's integrated capabilities in tissue processing and biologic innovation provide surgeons ...

4/ 10Mixed

Cyborg Score thesis

Turnaround candidate with strong orthobiologics core but facing financial distress and requiring successful execution of...

Read the full analyst-debate transcript →
Industry Medical Devices - Orthobiologics and Spinal Implants
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Xtant Medical Holdings, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Xtant Medical Holdings, Inc.

AskCyborg analysts argue the bull and bear cases for Xtant Medical Holdings, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Xtant Medical Holdings, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Xtant Medical Holdings, Inc. Overview

Pro stress-test →

Xtant Medical is a tissue bank and developer of orthobiologics and spinal fixation systems headquartered in Montana. The company's integrated capabilities in tissue processing and biologic innovation provide surgeons with scientifically engineered solutions for a wide range of procedures. The company achieved record annual revenues of $91.3 million in 2023, up 58% year-over-year.

Strategic Profile

Pro stress-test →

Xtant Medical is executing a strategic transformation to concentrate on its core orthobiologics business and develops a comprehensive portfolio of regenerative products designed to promote bone and tissue healing in spinal and orthopedic procedures. The company has established exceptional market access through 450 integrated delivery network contracts and a network of more than 670 independent distributors.

Competitive Landscape

Pro stress-test →

Xtant competes in the orthobiologic implant market with a vertically integrated platform distinguished by inclusion of all five major orthobiologic categories plus amniotic membranes for advanced wound care. Main competitors include other orthobiologic and spine fixation manufacturers in this specialized surgical market segment.

Industry Context

Xtant Medical Holdings, Inc. operates in Medical Devices - Orthobiologics and Spinal Implants.

Key facts

Founded: 2000 · Headquarters: Belgrade, Montana · Revenue: $131M-$135M (FY2025 guidance) · Market cap: $79.8M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Xtant Medical Holdings, Inc..

  • Xtant's vertically integrated platform includes all five major orthobiologic categories with a comprehensive portfolio covering demineralized bone graft, cellular allograft, allograft, synthetic bone graft, and marrow-derived growth factor products.
  • Recent divestitures of Coflex assets and Paradigm OUS operations with total proceeds of $21.4 million are part of strategic realignment to improve liquidity and reduce debt.
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • March 2026Completed asset sale to Companion Spine with final $10.7M payment, bringing total divestitures to $21.4M for debt reduction and liquidity enhancement
  • November 2025Q3 2025 revenue of $33.3M increased 19% YoY with positive net income and adjusted EBITDA; maintained FY25 guidance of $131-$135M
  • +2 moreTrack every material event for Xtant Medical Holdings, Inc. as it happens. Explore monitoring →
Get alerted when Xtant Medical Holdings, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare Xtant Medical Holdings, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Xtant Medical Holdings, Inc. operates in Medical Devices - Orthobiologics and Spinal Implants. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices - Orthobiologics and Spinal Implants research →
NEW · MCP server

Ask your AI assistant about Xtant Medical Holdings, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Xtant Medical Holdings, Inc. and its top competitor on Cyborg Score”
“What did Xtant Medical Holdings, Inc. do this quarter?”
“Is Xtant Medical Holdings, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Xtant Medical Holdings, Inc. do?+
Xtant Medical is a tissue bank and developer of orthobiologics and spinal fixation systems headquartered in Montana. The company's integrated capabilities in tissue processing and biologic innovation provide surgeons ...
What is Xtant Medical Holdings, Inc.'s Cyborg Score?+
Xtant Medical Holdings, Inc. has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Xtant Medical Holdings, Inc.'s main competitors?+
Named competitors include Orthobiologic and Spinal Implant Solutions, Regenerative Medicine Products, Spinal Fusion Systems. The full competitive landscape is in the AskCyborg report.
How can I get the full Xtant Medical Holdings, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Xtant Medical Holdings, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Xtant Medical Holdings, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual